Obagi Medical Products, Inc. (OMPI)
$11.18
-0.12 (-1.06%)
| CAPS Rating |
|
|---|---|
| Open | $11.30 |
| Previous Close | $11.30 |
| Daily Range | $11.07 - $11.31 |
| 52-Week Range | $3.79 - $11.80 |
| Market Cap | $244.98M |
| P/E Ratio | 28.82 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 26,036 |
| Average Daily Volume | 65,000 |
OMPI
VS S&P 500 (SPY)
How do you think OMPI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OMPI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OMPI News and Commentary
- Today's 5-Star Movers – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 3 More Outrageously Cheap Stocks – The Motley Fool
- Technical Analysis: A Damning Verdict – The Motley Fool
- Closing OMPI (Obagi) outperform – Blog at The Motley Fool
Related News and Articles
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
RSS Headlines
Fool UK
